Linden Thomas Advisory Services, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1965702 Charlotte, NC

Position in BMY

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$1,764,209

-$45,162 QoQ

Shares Held

30,618

+2.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#890

of 2,506 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $22,830,139 across 6 Drug Manufacturers - General names. BMY ranks #6 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,333	$7,595,990
2	ABBV	AbbVie Inc.	15,041	$3,784,917
3	GILD	Gilead Sciences, Inc.	27,150	$3,430,131
4	MRK	Merck & Co., Inc.	25,106	$3,226,121
5	AMGN	Amgen Inc	8,364	$3,028,771
6	BMY	Bristol Myers Squibb Co This page	30,618	$1,764,209

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,764,209	30,618	+2.6%	Shares	Sole	2026-07-16
2026-03-31	$1,809,371	29,833	+6.5%	Shares	Sole	2026-04-10
2025-12-31	$1,511,129	28,015	-0.7%	Shares	Sole	2026-01-16
2025-09-30	$1,272,451	28,214	+1.5%	Shares	Sole	2025-11-06
2025-06-30	$1,286,769	27,798	+3.9%	Shares	Sole	2025-07-31
2025-03-31	$1,630,994	26,742	+2.4%	Shares	Sole	2025-04-30
2024-12-31	$1,476,385	26,103	-1.9%	Shares	Sole	2025-01-21
2024-09-30	$1,376,904	26,612	-1.0%	Shares	Sole	2024-10-17
2024-06-30	$1,116,243	26,878	-36.8%	Shares	Sole	2024-07-10
2024-03-31	$2,306,835	42,538	+7.0%	Shares	Sole	2024-04-30
2023-12-31	$2,040,342	39,765	+3.4%	Shares	Sole	2024-02-01
2023-09-30	$2,231,579	38,449	+54.0%	Shares	Sole	2023-10-20
2023-06-30	$1,596,255	24,961	+3.0%	Shares	Sole	2023-07-27
2023-03-31	$1,679,589	24,233	+11.4%	Shares	Sole	2023-04-25
2022-12-31	$1,565,416	21,757	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.